Protecting Children from Wildfire Smoke
Smoke from wildfires in Canada is affecting air quality in parts of the U.S. Northeast. Understand the risks to children and how to protect them.
Category: In the News
Mount Sinai Spinoff Startup LinusBio Raises $16 Million in Series A funding
LinusBio, a 2021 spinoff company from Mount Sinai, announced a Series A venture capital funding to deliver a novel platform that bridges genomics, the environment, and biological response. The company’s platform is based on new methods and technology developed by scientists at the Institute for Exposomic Research at Mount Sinai.
Study Finds: Exposure to PFAS Found in Everyday Products Is Linked to Significantly Reduced Fertility
Researchers from Mount Sinai Institute for Exposomic Research found that exposure to chemicals commonly found in drinking water and everyday household products may result in reduced fertility in women by as much as 40 percent
A New Tool for Estimating People’s Total Exposure to Potentially Harmful Chemicals Is Developed by Mount Sinai Researchers
A novel metric that estimates our “burden,” or cumulative exposure, to a family of thousands of synthetic chemicals that we encounter in everyday life with potentially adverse health impacts, has been created by a team of researchers at the Mount Sinai Institute for Exposomics and Environmental Health
Icahn School of Medicine at Mount Sinai Receives National Institutes of Health Award to Accelerate Development of New Treatments
$55.5 million grant has potential to enhance innovation across medical disciplines such as precision medicine, exposomics, and public health.
WATCH: Rosalind J Wright, MD, MPH, Co-Director of The Institute for Exposomic Research, Awarded a 2022 Jacobi Medallion
This year’s Jacobi Medallion awards were presented to 11 accomplished physicians and researchers by the Mount Sinai Alumni Association and the Icahn School of Medicine at Mount Sinai
Prenatal Exposure to Chemicals in Consumer and Industrial Products Is Associated With Rising Liver Disease in Children
Researchers from the Institute for Exposomic Research at Mount Sinai found that the growing incidence of a potentially cancer-causing liver disease in children is associated with prenatal exposure to several endocrine-disrupting chemicals
New Theory Sheds Light on How the Environment Influences Human Health
In a new book, Dr. Manish Arora and Dr. Paul Curtin of the Mount Sinai Institute for Exposomic Research suggest that a newly proposed component—the biodynamic interface—may better explain how humans interact with their environment
Harnessing the ‘Exposome’ to Diagnose Autism
In an interview with Spectrum magazine, Dr. Manish Arora described what is next for the company’s hair based early autism diagnosis tool, StrandDx
Chronic Exposure to Air Pollution May Increase Risks for ICU Admission or Death Among COVID-19 Patients
New study suggests persistent exposure to air pollutants in residential communities can impact health outcomes for COVID-19 patients
Mount Sinai Spin-Off Company, Linus Biotechnology Inc., Receives FDA Breakthrough Device Designation for its ASD Diagnostic Product
StrandDx™- ASD Exposome Sequencing Diagnostic was developed based on technology developed by researchers in the Institute for Exposomic Research at Mount Sinai.
Childhood Asthma Study Uncovers Risky Air Pollutant Mixtures
Researchers use a novel machine learning algorithm to discover that early exposure to a variety of toxic air pollutants can lead to poor asthma outcomes
New York Governor Announces Study To Explore Effects Of Climate Change On NY Communities
Collaborative Climate Research Effort to Be Conducted in Partnership with Academic Institutions, Science Organizations, Community Leaders, and Industry Representatives. Dr. Perry Sheffield of the Institute for Exposomic Research will lead the Health and Safety Workgroup
Mount Sinai Spin-Off Company, Linus Biotechnology Inc., to Revolutionize Precision Medicine with Exposome Sequencing
Subject to regulatory approvals, the new company intends to launch its first product with StrandDx™- ASD a molecular biomarker for autism spectrum disorder that can be applied at birth, and can assist in early Autism Spectrum Disorder diagnosis.
Rescue and recovery workers and volunteers who arrived early at the World Trade Center site face higher risk of developing COPD
Rescue and recovery workers who attended the World Trade Center site are beginning to develop chronic obstructive pulmonary disease (COPD), according to research presented at the European Respiratory Society International Congress by Mount Sinai researchers.
Disadvantaged Neighborhoods See More COVID-19 Infections and Deaths
A new peer-reviewed study in Nature Communications shows how pre-existing neighborhood social factors like housing, work, income, insurance help explain the higher rates of infection for COVID19 in communities of color.
In Utero Exposure to Tiny Pollution Particles in the Air Is Linked to Asthma in Preschoolers
Researchers from the Mount Sinai Institute for Exposomic Research are first to find ultrafine particles from traffic pollution influences asthma risk in U.S. children
Zinc and Copper Metabolic Cycles in Baby Teeth Linked to Autism
Mount Sinai Research Could Result in Early Diagnostic System for Autism Spectrum Disorder